NEI Research News

Researchers are making progress toward understanding how some cases of glaucoma begin.

By borrowing a tool from bacteria that infect plants, scientists have developed a new approach to eliminate mutated DNA inside mitochondria—the energy factories within cells.

Researchers have achieved dynamic, atomic-scale views of a protein needed to maintain the transparency of the lens in the human eye.

Ronald Davis, Ph.D., an NEI grantee and a geneticist at Stanford University School of Medicine, has been selected to receive an award from the Warren Alpert Foundation.

At the suggestion of a National Eye Institute employee who is deaf, NIH recently amended its official mission statement.

Anthony Movshon, Ph.D., an NEI grantee and director of New York University’s Center for Neural Science, has won the 2013 Karl Spencer Lashley Award from the American Philosophical Society (APS).

Stephen J. Ryan, M.D., highly regarded for his leadership and tireless advocacy on behalf of the NEI, passed away April 29, 2013.

Three researchers supported in part by NEI have been elected to the National Academy of Sciences, a nonprofit organization that advises the U.S. government on matters of science and technology.

Adding omega-3 fatty acids did not improve a combination of nutritional supplements commonly recommended for treating age-related macular degeneration (AMD), a major cause of vision loss among older Americans.

Targeting cholesterol metabolism in the eye might help prevent a severe form of age-related macular degeneration (AMD), one of the most common causes of blindness in older Americans.